We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current BNKL market cap is 12.48. The company's latest EPS is USD -0.3963 and P/E is 0.00.
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.32M | 2.25M | 1.19M | 1.27M | 1.81M |
| Operating Income | -9.42M | -24.99M | -13.34M | -9.97M | -4.83M |
| Net Income | -10.56M | -25.02M | -13.62M | -10.41M | -4.95M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 30.68M | 18.52M | 8.79M | 4.68M | 3.36M |
| Total Liabilities | 3.27M | 5.2M | 5.51M | 1.75M | 5M |
| Total Equity | 27.41M | 13.32M | 3.28M | 2.93M | -1.64M |
| Year End 31 March 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -9.23M | -9.06M | -4.62M | -4.15M | -3.39M |
| Investing | -102k | -160k | N/A | -13k | -224k |
| Financing | 9.27M | 11.05M | 2.96M | 5.55M | 2.05M |
| Market Cap | 12.48 |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 12.48M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 7.8k |
| 52 Week Change | 0.00% |
| 52 Week High | 0.0001 |
| 52 Week Low | 0.000001 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Bionik Laboratories Corporation (CE) |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bioniklabs.com |
| Industry | ortho,prosth,surg appl,suply (3842) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
